Serum electrolytes and renal alterations in HIV-seropositive Mexican subjects

To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, chole...

Full description

Saved in:
Bibliographic Details
Published inMedicine (Baltimore) Vol. 100; no. 20; p. e26016
Main Authors Garza Tovar, Oscar Antonio, Pérez, Alberto Alejandro Miranda, Pérez, María Elena Gutiérrez, Robledo, Ivonne Urraza, Galarza, Faviel F. González, Márquez, Francisco Carlos López
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 21.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate  < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations.
AbstractList To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate  < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations.ABSTRACTTo examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate  < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations.
To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment. This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate  < 60 mL/min/1.73 m 2 . Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis. CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 ( P  = .02; OR 0.2; CI 95% 0.08–0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia ( P  = .02; OR 5.1; CI 95% 1.2–21.3), hypocalcemia ( P  = .01; OR 4.1; CI 95% 1.3–12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1–13.6). Patient age was associated to both hypophosphatemia ( P  = .01; OR 2.4; CI 95% 1.1–5.0) and hypermagnesemia ( P  = .01; OR 2.8; IC 95% 1.1–7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment ( P  = .001; OR 42.5; CI 95% 2.2–806.9). Lastly, high BUN levels were associated to age ( P  = .03; OR 3.8; CI 95% 1.0–14.4), while GFR 60 to 89 mL/min/1.73 m 2 was associated to dyslipidemia ( P  = .02; OR 2.2; CI 95% 1.1–4.5). CD4+ T cell and viral load were the main factors associated with renal biochemical alterations.
To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate  < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations.
Author Garza Tovar, Oscar Antonio
Pérez, María Elena Gutiérrez
Robledo, Ivonne Urraza
Pérez, Alberto Alejandro Miranda
Galarza, Faviel F. González
Márquez, Francisco Carlos López
AuthorAffiliation Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México
AuthorAffiliation_xml – name: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
– name: High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México
– name: b High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México
– name: a Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
Author_xml – sequence: 1
  givenname: Oscar Antonio
  surname: Garza Tovar
  fullname: Garza Tovar, Oscar Antonio
  organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
– sequence: 2
  givenname: Alberto Alejandro Miranda
  surname: Pérez
  fullname: Pérez, Alberto Alejandro Miranda
  organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
– sequence: 3
  givenname: María Elena Gutiérrez
  surname: Pérez
  fullname: Pérez, María Elena Gutiérrez
  organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
– sequence: 4
  givenname: Ivonne Urraza
  surname: Robledo
  fullname: Robledo, Ivonne Urraza
  organization: High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México
– sequence: 5
  givenname: Faviel F. González
  surname: Galarza
  fullname: Galarza, Faviel F. González
  organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
– sequence: 6
  givenname: Francisco Carlos López
  surname: Márquez
  fullname: Márquez, Francisco Carlos López
  organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34011103$$D View this record in MEDLINE/PubMed
BookMark eNp9UcluFDEQtVAQmQS-AAn1kUuH8tZuX5BQEkikjDiwXC23u4Zx8NiD3Z2Qv8fJJCw5UJJVUvkt0nsHZC-miIS8pHBEQas3y5Mj-DOsA9o9IQsqeddK3Yk9sqhX2SqtxD45KOUSgHLFxDOyzwVQSoEvyPIT5nnTYEA35RRuJiyNjWOTMdrQ2DBhtpNPsTQ-NmfnX9uCOW1T8ZO_wmaJP72zsSnzcFkFynPydGVDwRf3-5B8eX_6-fisvfj44fz43UXrhATR9kKNIKwCgXIckHVUUo7jIKxmTDGunBiGjvYrzeXYDyNzMHaAbOVkRVjND8nbne52HjY4OoxTtsFss9_YfGOS9ebfn-jX5lu6Mn1NoOZUBV7fC-T0Y8YymY0vDkOwEdNcDJNMa8qFggp99bfXb5OHDCtA7wAup1Iyrozz011o1doHQ8Hc9mWWJ-ZxX5XLH3Ef5P_PEjvWdbotqHwP8zVms8ba1_oOLpVmLQNGQdbX1ksv-C9jIqdv
CitedBy_id crossref_primary_10_3389_fcvm_2022_968184
crossref_primary_10_1161_CIRCRESAHA_124_323948
Cites_doi 10.2337/dc20-S002
10.1038/nrneph.2009.141
10.18203/2320-6012.ijrms20183276
10.1016/j.kint.2017.11.007
10.1016/j.nefro.2019.01.009
10.1001/jama.1990.03440070061033
10.5897/AJCPATH15.001
10.1186/s12882-017-0470-4
10.1093/ndt/gfr657
10.1007/s11904-005-0002-x
10.1097/QAI.0b013e318222f461
10.1016/j.bjid.2018.05.001
10.1371/journal.pone.0111077
10.1097/QAI.0000000000000259
10.1089/aid.2010.0345
10.1371/journal.pone.0093748
10.4172/2161-0681.1000134
10.3947/ic.2017.49.3.194
10.1159/000092247
10.1038/nrneph.2013.143
10.5414/CNP83S032
10.5527/wjn.v5.i1.33
10.1016/0002-9343(93)90179-S
10.1056/NEJMra1508467
10.1053/j.ackd.2009.08.006
10.5527/wjn.v4.i3.388
10.1093/ndt/gfm836
10.1371/journal.pone.0010687
10.7326/0003-4819-112-1-35
10.1186/s12879-017-2191-5
10.1056/NEJM199302043280508
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021
Copyright_xml – notice: Lippincott Williams & Wilkins
– notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
– notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1097/MD.0000000000026016
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5964
EndPage e26016
ExternalDocumentID PMC8137016
34011103
10_1097_MD_0000000000026016
00005792-202105210-00084
Genre Journal Article
Observational Study
GeographicLocations Mexico
GeographicLocations_xml – name: Mexico
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABCQX
ABDIG
ABFRF
ABOCM
ABVCZ
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADGGA
ADHPY
ADNKB
ADPDF
AE6
AEFWE
AENEX
AFBFQ
AFDTB
AGOPY
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
CS3
DIWNM
DU5
E.X
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FD6
FIJ
FL-
GNXGY
GQDEL
GROUPED_DOAJ
H0~
HLJTE
HYE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
N9A
N~7
N~B
O9-
OAG
OAH
OB2
OHH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVEED
OVIDH
OVLEI
OWV
OWW
OWZ
OXXIT
P2P
RIG
RLZ
RPM
RXW
S4R
S4S
TAF
TEORI
TSPGW
UNMZH
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
YOC
ZFV
ZY1
AAYXX
ADSXY
CITATION
8L-
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
ODA
7X8
5PM
ID FETCH-LOGICAL-c4504-847d04a704e5dbe261513edb4a9227237c4bb618f935d8bd2c0d60e2fc5a92a93
ISSN 0025-7974
1536-5964
IngestDate Thu Aug 21 14:34:14 EDT 2025
Thu Jul 10 21:58:41 EDT 2025
Wed Feb 19 02:24:44 EST 2025
Tue Aug 05 12:06:25 EDT 2025
Thu Apr 24 23:04:47 EDT 2025
Fri May 16 03:48:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 20
Language English
License Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4504-847d04a704e5dbe261513edb4a9227237c4bb618f935d8bd2c0d60e2fc5a92a93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0003-2939-7411
OpenAccessLink http://dx.doi.org/10.1097/MD.0000000000026016
PMID 34011103
PQID 2529913470
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8137016
proquest_miscellaneous_2529913470
pubmed_primary_34011103
crossref_citationtrail_10_1097_MD_0000000000026016
crossref_primary_10_1097_MD_0000000000026016
wolterskluwer_health_00005792-202105210-00084
PublicationCentury 2000
PublicationDate 20210521
2021-05-21
2021-May-21
PublicationDateYYYYMMDD 2021-05-21
PublicationDate_xml – month: 05
  year: 2021
  text: 20210521
  day: 21
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hagerstown, MD
PublicationTitle Medicine (Baltimore)
PublicationTitleAlternate Medicine (Baltimore)
PublicationYear 2021
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References Obum-Nnadi (R6-20250504) 2013; 03
Domingo (R29-20250504) 2019; 39
Ugwuja (R34-20250504) 2012; 2
Vitting (R40-20250504) 1990; 263
Epstein (R47-20250504) 1993; 328
Braconnier (R38-20250504) 2017; 17
Emejulu (R35-20250504) 2011; 5
Swanepoel (R5-20250504) 2018; 93
Afhami (R7-20250504) 2007; 10
Olaniyan (R36-20250504) 2004; 1
Ibrahim (R20-20250504) 2012; 27
Emem (R24-20250504) 2008; 23
Fabian (R23-20250504) 2009; 5
Naicker (R2-20250504) 2015; 83
Dao (R8-20250504) 2011; 27
Cristelli (R3-20250504) 2017; 18
Ando (R26-20250504) 2015; 4
Damor (R32-20250504) 2018; 6
Kalyesubula (R1-20250504) 2014; 67
Berggren (R10-20250504) 2005; 2
Schneider (R15-20250504) 2008; 57
Glassock (R9-20250504) 1990; 112
Eshiet (R30-20250504) 2015; 4
Heimburger (R42-20250504) 2010; 5
Levin (R16-20250504) 2013; 3
Juega-Mariño (R27-20250504) 2017; 96
CN (R43-20250504) 2013; 03
Delanaye (R17-20250504) 2013; 9
Winston (R46-20250504) 2010; 17
Santiago (R22-20250504) 2014; 9
Wikman (R41-20250504) 2010; 13
Nwauche (R33-20250504) 2019; 8
Levey (R12-20250504) 2002; 39
Xu (R37-20250504) 2014; 9
González-López (R21-20250504) 2014; 34
Bagnis (R45-20250504) 2006; 103
Cohen (R4-20250504) 2017; 377
Association (R13-20250504) 2020; 43
Tang (R39-20250504) 1993; 94
Musso (R11-20250504) 2016; 5
Samson (R31-20250504) 2018; 7
Kim (R28-20250504) 2017; 49
Estrella (R19-20250504) 2011; 57
Cristelli (R25-20250504) 2018; 22
References_xml – volume: 39
  issue: (2 SUPPL. 1)
  year: 2002
  ident: R12-20250504
  article-title: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
  publication-title: Am J Kidney Dis
– volume: 3
  start-page: 01
  year: 2013
  ident: R16-20250504
  article-title: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
  publication-title: Kidney Int Suppl
– volume: 43
  start-page: S14
  issue: (Supplement 1)
  year: 2020
  ident: R13-20250504
  article-title: 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020
  publication-title: Diabetes Care
  doi: 10.2337/dc20-S002
– volume: 5
  start-page: 591
  year: 2009
  ident: R23-20250504
  article-title: HIV and kidney disease in sub-Saharan Africa
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2009.141
– volume: 6
  start-page: 2818
  year: 2018
  ident: R32-20250504
  article-title: A prospective study of serum electrolyte disorders and their clinical manifestation in HIV patients
  publication-title: Int J Res Med Sci
  doi: 10.18203/2320-6012.ijrms20183276
– volume: 93
  start-page: 545
  year: 2018
  ident: R5-20250504
  article-title: Kidney disease in the setting of HIV infection: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2017.11.007
– volume: 39
  start-page: 497
  year: 2019
  ident: R29-20250504
  article-title: Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: results from the VACH longitudinal cohort study
  publication-title: Nefrología
  doi: 10.1016/j.nefro.2019.01.009
– volume: 263
  start-page: 973
  year: 1990
  ident: R40-20250504
  article-title: Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immuno deficiency syndrome
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.1990.03440070061033
– volume: 4
  start-page: 01
  year: 2015
  ident: R30-20250504
  article-title: Plasma urea and electrolytes profile in different stages of hiv infection in Ekpoma
  publication-title: Nigeria African J Cell Pathol
  doi: 10.5897/AJCPATH15.001
– volume: 18
  start-page: 01
  year: 2017
  ident: R3-20250504
  article-title: Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis
  publication-title: BMC Nephrol
  doi: 10.1186/s12882-017-0470-4
– volume: 27
  start-page: 2291
  year: 2012
  ident: R20-20250504
  article-title: Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfr657
– volume: 8
  start-page: 01
  year: 2019
  ident: R33-20250504
  article-title: Comparative study on the electrolyte levels of HIV/AIDS patients on high active antiretroviral therapy (HAART) in owerri metropolis
  publication-title: South Eastern Nigeria Int STD Res Rev
– volume: 2
  start-page: 109
  year: 2005
  ident: R10-20250504
  article-title: HIV-associated renal disorders: recent insights into pathogenesis and treatment
  publication-title: Curr HIV/AIDS Rep
  doi: 10.1007/s11904-005-0002-x
– volume: 10
  start-page: 335
  year: 2007
  ident: R7-20250504
  article-title: Renal disorders in HIV-infected patients
  publication-title: Arch Iran Med
– volume: 57
  start-page: 380
  year: 2011
  ident: R19-20250504
  article-title: Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e318222f461
– volume: 03
  start-page: 03
  year: 2013
  ident: R6-20250504
  article-title: Assay of the level of calcium, magnesium and inorganic phosphorus in HIV infected patients in Owerri
  publication-title: Southeast Nigeria J Clin Exp Pathol
– volume: 22
  start-page: 193
  year: 2018
  ident: R25-20250504
  article-title: Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy
  publication-title: Brazilian J Infect Dis
  doi: 10.1016/j.bjid.2018.05.001
– volume: 9
  start-page: e111077
  year: 2014
  ident: R37-20250504
  article-title: Moderate/severe hyponatremia increases the risk of death among hospitalized chinese human immunodeficiency virus/acquired immunodeficiency syndrome patients
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0111077
– volume: 67
  start-page: 68
  issue: (Suppl.1)
  year: 2014
  ident: R1-20250504
  article-title: HIV-associated renal and genitourinary comorbidities in Africa
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000000259
– volume: 1
  start-page: 29
  year: 2004
  ident: R36-20250504
  article-title: Comparative study of plasma electrolytes (Na, K, Cl, and HCO3) and urea levels in HIV/AIDS and pulmonary tuberculosis infected subjects
  publication-title: Niger Soc Exp Biol
– volume: 27
  start-page: 1149
  year: 2011
  ident: R8-20250504
  article-title: Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2010.0345
– volume: 9
  start-page: e93748
  year: 2014
  ident: R22-20250504
  article-title: Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country
  publication-title: Burdmann EA, ed PLoS One
  doi: 10.1371/journal.pone.0093748
– volume: 03
  start-page: 03
  year: 2013
  ident: R43-20250504
  article-title: Assay of the level of calcium, magnesium and inorganic phosphorus in HIV infected patients in Owerri, southeast Nigeria
  publication-title: J Clin Exp Pathol
  doi: 10.4172/2161-0681.1000134
– volume: 49
  start-page: 194
  year: 2017
  ident: R28-20250504
  article-title: The prevalence and risk factors of renal insufficiency among Korean HIV-infected patients: the Korea HIV/AIDS cohort study
  publication-title: Infect Chemother
  doi: 10.3947/ic.2017.49.3.194
– volume: 103
  start-page: 131
  year: 2006
  ident: R45-20250504
  article-title: Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era
  publication-title: Nephron - Physiol
  doi: 10.1159/000092247
– volume: 9
  start-page: 513
  year: 2013
  ident: R17-20250504
  article-title: The applicability of eGFR equations to different populations
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2013.143
– volume: 83
  start-page: S32
  year: 2015
  ident: R2-20250504
  article-title: HIV and chronic kidney disease
  publication-title: Clin Nephrol
  doi: 10.5414/CNP83S032
– volume: 5
  start-page: 33
  year: 2016
  ident: R11-20250504
  article-title: Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v5.i1.33
– volume: 96
  year: 2017
  ident: R27-20250504
  article-title: Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
  publication-title: Med (United States)
– volume: 94
  start-page: 169
  year: 1993
  ident: R39-20250504
  article-title: Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex
  publication-title: Am J Med
  doi: 10.1016/0002-9343(93)90179-S
– volume: 377
  start-page: 2363
  year: 2017
  ident: R4-20250504
  article-title: Kidney diseases associated with human immunodeficiency virus infection
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1508467
– volume: 17
  start-page: 19
  year: 2010
  ident: R46-20250504
  article-title: HIV and CKD epidemiology
  publication-title: Adv Chronic Kidney Dis
  doi: 10.1053/j.ackd.2009.08.006
– volume: 34
  start-page: 126
  year: 2014
  ident: R21-20250504
  article-title: Prevalencia de enfermedad renal crónica en pacientes infectados por el virus de la inmunodeficiencia humana
  publication-title: Nefrologia
– volume: 4
  start-page: 388
  year: 2015
  ident: R26-20250504
  article-title: Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v4.i3.388
– volume: 23
  start-page: 741
  year: 2008
  ident: R24-20250504
  article-title: Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfm836
– volume: 5
  year: 2010
  ident: R42-20250504
  article-title: Serum phosphate predicts early mortality in adults starting antiretroviral therapy in lusaka, zambia: a prospective cohort study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010687
– volume: 7
  start-page: 5928
  year: 2018
  ident: R31-20250504
  article-title: Effects of highly active antiretroviral therapy (HAART) on some serum micronutrients and electrolytes levels in HIV infected patients in Southern Nigeria
  publication-title: Biomed J Sci Tech Res
– volume: 112
  start-page: 35
  year: 1990
  ident: R9-20250504
  article-title: Human immunodeficiency virus (HIV) infection and the kidney
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-112-1-35
– volume: 17
  year: 2017
  ident: R38-20250504
  article-title: Hyponatremia is a marker of disease severity in HIV-infected patients: a retrospective cohort study
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-017-2191-5
– volume: 5
  start-page: 257
  year: 2011
  ident: R35-20250504
  article-title: Electrolyte abnormalities and renal impairment in asymptomatic HIV-infected patients in Owerri
  publication-title: South Eastern Nigeria Aust J Basic Appl Sci
– volume: 328
  start-page: 327
  year: 1993
  ident: R47-20250504
  article-title: The Immunopathogenesis of human immunodeficiency virus infection
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199302043280508
– volume: 57
  start-page: 01
  issue: (RR-10)
  year: 2008
  ident: R15-20250504
  article-title: Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008
  publication-title: MMWR Recomm Rep
– volume: 13
  start-page: P150
  issue: (Suppl 4)
  year: 2010
  ident: R41-20250504
  article-title: Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen
  publication-title: J Int AIDS Soc
– volume: 2
  start-page: 01
  year: 2012
  ident: R34-20250504
  article-title: A Comparative study of serum electrolytes, total protein, calcium and phosphate among diabetic and HIV/AIDS patients in abakaliki, southeastern
  publication-title: Nigeria Internet J Lab Med
SSID ssj0013724
Score 2.3421655
Snippet To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e26016
SubjectTerms Adult
Aged
Anti-Retroviral Agents - therapeutic use
Electrolytes - blood
Female
Glomerular Filtration Rate - physiology
HIV Seropositivity - blood
HIV Seropositivity - complications
HIV Seropositivity - drug therapy
Humans
Male
Mexico
Middle Aged
Observational Study
Prevalence
Renal Insufficiency, Chronic - diagnosis
Renal Insufficiency, Chronic - epidemiology
Risk Factors
Young Adult
Title Serum electrolytes and renal alterations in HIV-seropositive Mexican subjects
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-202105210-00084
https://www.ncbi.nlm.nih.gov/pubmed/34011103
https://www.proquest.com/docview/2529913470
https://pubmed.ncbi.nlm.nih.gov/PMC8137016
Volume 100
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJyEkhLhTLlOQeCsZrmPXyWOhhQ4p7KWb9hY5saMVSoLSdkD_Hn-MYztJk66aGH2IqtR1nZ7Px8fn8hmhNwS2xmkaDFzOFHEpINgVwhcuSf1UeCTlUmqHfvhlOD2ln8_Zeafzp5G1tF7FR8lmb13J_0gV7oFcdZXsDSRbdwo34D3IF64gYbj-k4xhoq-_98uTbBa_tQvVpIsrbWKaOPg2VXx6fObCoHKbpaWPHFK_jApcrmPti1k2zdSwjLhr-_M9dDS36bi10-CTKDaiP8svbXr2yTIRheYhAAWR18rWxuAL66IeaS4tsHNHC_VVaJKEfjgvRMMf0G4eChvCH4v-BNZFAVBezcsW0GQbJooXShpv7_GlTtnpnxaF2IimL4MMdBjeFkjXtQWaQNOe23OkKpU8dFlguc5rnY1xA5wEN1SwMiRpe1cHyzocji1ppX3Vrdtc3DtrZJ25WMXsw3G028ktdEBgr0K66ODkbDIZb4NZnND65GB4uIr8KuDv9oylbSBd2fVcTd69-zPXgFp-M3UVDetodh_dK7c1zshi9AHqqOwhul3B6BEKDVSdJlQdkL5joOo0oOrMM2cXqk4JVaeC6mN0-nEy-zB1y5M83IQyTF0wgSSmgmOqmIxBQmBnekrGVASEcOLxhMbxcOCngcekH0uSYDnEiqQJgxYi8J6gbpZn6hlyYok9BSu4FAGjA64CzkCveAFWWBCucA-R6u-LkpLmXp-2soiuEV0Pva2_9MOyvFzf_HUllwi0sQ6xiUzl62VEGJh3ujobxvHUyqnu0KOwlg6w10O8JcG6gWZ6b3-SzS8M47sPGDK_67ZkHdlaaTM-xgPi6jmlq_ENWYRPn9_ssV6gO9tJ-RJ1V8VavQKTexUfGlfVYQnsv_e8zOE
linkProvider Ovid
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3bbtMw1IJOgkkIcR3laiSUJwyuY9fJQx-qNqMbS0Fqd-EpcmJHTIxkWtoBf885SVooE0jkJZF8cpHPyblfCHklwDTO87DHtHKCSaBgZkxgmMiD3Pgi19aiQz-e9ieHcv9EnbTZFlgLg9Vn1fkbPNV8Gi9wHg4ahvPB_sybRsezQeGNZqPBJ-_j8F1U-6kxS8IbD8rLfOENp3X-ldKhABoAkwYkVF09HcjrZKuvhOYdsvXhKIrGv-INWsj1cFdQsVf9iUL9Nh43PQ6bo-7AtSnDriimV_Mrb30rMfZdfalT338TYLt3yO1W86TDhlTukmuuuEduxG1s_T6JgW0sv9J2Ls7ZD9BBqSksvXB4Wx1Vb7x79LSgk70jBsRbNjlfl47G7jsyVFotU_TsVA_I4W40H01YO2yBZVJxyUBKWS6N5tIpmzqBmo7vbCpNKIQWvs5kmvZ7QR76ygapFRm3fe5EnimAMKH_kHSKsnCPCE0t9x0wWWtCJXvahVoB6v2QO26EdrxLxGr7kqztRI4DMc6SVUQ8Hid_7nmXvF7fdN404vg3-MsVXhL4YTAKYgpXLqtEKJDAWEAL37HT4Gn9QB-sTdCH_C7RGxhcA2Az7s2V4vRz3ZQ7ABqq38s2cJ005azJ3yjy8X_CvyA3J_P4IDnYm75_QrZxFXMZRO8p6Swulu4ZqEiL9HlL3z8BIyMD-g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1rT9sw0GJFQpMmxN5lr0ya8mmeXD_q5EM-oCZdYUtBKjD4FDmxoyEgQaRl499zzqNbxzRp-ZJIPieW73K-9yH0gYJqnOf-AEthKOZAwVgpT2Gae7liNJdaW4N-PB1OjvjeiThZQ53H1CafVVef7K1m0_bBtsOxeuFhsDdzR7NRcOpOo2-zYOoe7HyOajO1DZJwD8JxcOuGQXmTz91wP-jqM8ZhU6SwueoSWg_QuucNCe-h9f3jKAp_-R0k5csmryBqd3WK_v6a1bPsnoB6P87y0Y_S-sCr8zoE_reDbLyFNlsJ1NlpSOYxWjPFE7QRtz72pygG9rG4dNr-OBe3IIs6qtDOtbHTau96Y-VzzgpnsnuMgYjLJvbrxjix-WkZq1MtUmvhqZ6ho3F0OJrgtukCzrggHMNppQlXknAjdGqolXiY0SlXPqWSMpnxNB0OvNxnQnupphnRQ2JongmAUD57jnpFWZiXyEk1YQaYrVa-4ANpfCmABJhPDFFUGtJHtNu-JGsrktvGGBdJ5xmPw-TPPe-jj8tJV01Bjn-Dv-_wksCPY70hqjDlokqogJPYJtLCOl40eFq-kIHWCXIR6yO5gsElgC3KvTpSnH2vi3N7QEP1d_EKrpMmrbVen5A-Be4EyjbITnVev8e3_xP-HdoAek--7k6_vEIP7aANaaCD16g3v16YNyApzdO3LXnfARTSBYY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+electrolytes+and+renal+alterations+in+HIV-seropositive+Mexican+subjects&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Garza+Tovar%2C+Oscar+Antonio&rft.au=P%C3%A9rez%2C+Alberto+Alejandro+Miranda&rft.au=P%C3%A9rez%2C+Mar%C3%ADa+Elena+Guti%C3%A9rrez&rft.au=Robledo%2C+Ivonne+Urraza&rft.date=2021-05-21&rft.issn=0025-7974&rft.eissn=1536-5964&rft.volume=100&rft.issue=20&rft.spage=e26016&rft_id=info:doi/10.1097%2FMD.0000000000026016&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_MD_0000000000026016
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon